Literature DB >> 17570031

Effect of proton pump inhibitor on amylase release from isolated pancreatic acini.

Jia Cai1, Wei Zhou, He-Sheng Luo, L V Peng.   

Abstract

Proton pump inhibitors (PPIs) could inhibit the secretion of gastric acid. Meanwhile, it could also decrease the secretion of other digestive glands besides gastric parietal cell. As we know, PPIs have been widely used to treat acute pancreatitis, and it is effective in clinical practice. However, research showed the side effect of PPIs on acute pancreatitis. The direct effect of PPI on pancreatic secretion is still unknown. Our experiment investigated the direct effect of PPIs on pancreatic exocrine by isolated pancreatic acini. In our study, isolated pancreatic acini were prepared as previously described by Williams, and cerulein was added to stimulate its secretion. The amylase release in the suspension was determined after the administration of different concentrations of omeprazole and Sandostatin; and its activity was also observed in different time phases. In our in vitro study, all results suggest that omeprazole has no direct repression on amylase release from isolated pancreatic acini.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570031     DOI: 10.1007/s11626-006-9004-2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  7 in total

1.  Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini.

Authors:  J A Williams; M Korc; R L Dormer
Journal:  Am J Physiol       Date:  1978-11

2.  Acute pancreatitis associated with omeprazole.

Authors:  S S Youssef; S B Iskandar; J Scruggs; T M Roy
Journal:  Int J Clin Pharmacol Ther       Date:  2005-12       Impact factor: 1.366

3.  Activation of proteases in cerulein-induced pancreatitis.

Authors:  H Yamaguchi; T Kimura; K Mimura; H Nawata
Journal:  Pancreas       Date:  1989       Impact factor: 3.327

4.  The risk of acute pancreatitis associated with acid-suppressing drugs.

Authors:  I A Eland; C H Alvarez; B H Stricker; L A Rodríguez
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

5.  Inhibition of iron absorption by omeprazole in rat model.

Authors:  J Golubov; P Flanagan; P Adams
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

6.  Hepatic iron and iron absorption in hemochromatosis.

Authors:  P C Adams; J V Frei; C Bradley; D Lam
Journal:  Clin Invest Med       Date:  1990-10       Impact factor: 0.825

7.  Temporary elevation of pancreatic lysosomal enzymes, as a result of the omeprazole-induced peripancreatic inflammation in male Wistar rats.

Authors:  F Burdan; Z Siezieniewska; R Maciejewski; K Burski; Z Wójtowicz
Journal:  J Physiol Pharmacol       Date:  2000-09       Impact factor: 3.011

  7 in total
  2 in total

Review 1.  Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.

Authors:  Carmelo Scarpignato; Luigi Gatta; Angelo Zullo; Corrado Blandizzi
Journal:  BMC Med       Date:  2016-11-09       Impact factor: 8.775

2.  ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Authors:  Stanley L Marks; Peter H Kook; Mark G Papich; M K Tolbert; Michael D Willard
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.